Molecular imaging determines effectiveness of novel metastatic breast cancer treatment ...Middle East

Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy. According to research published in the February issue of The Journal of Nuclear Medicine, positron emission tomography (PET) imaging using an imaging agent called 18F-fluoroestradiol can help to determine which patients could benefit from treatments that could spare them from unnecessary chemotherapy.

Hence then, the article about molecular imaging determines effectiveness of novel metastatic breast cancer treatment was published today ( Tuesday 16/02/2021 - 10:46 PM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Molecular imaging determines effectiveness of novel metastatic breast cancer treatment )

Also on site :

• OPEC+ makes first output decision after UAE exit – Reuters
• We Asked 7 Chefs for Their Favorite Frozen Meals and We're Obsessed With These Answers
• Strait of Hormuz blockade and other major naval sieges in modern times